Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Exchange Rate Effect (2023 - 2025)

Lexaria Bioscience's Exchange Rate Effect history spans 3 years, with the latest figure at -$5744.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 80.91% year-over-year to -$5744.0; the TTM value through Nov 2025 reached -$53088.0, down 94.01%, while the annual FY2025 figure was -$50519.0, 154.94% down from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$5744.0 at Lexaria Bioscience, down from $10738.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $37173.0 in Q2 2025 and bottomed at -$95255.0 in Q1 2025.
  • The 3-year median for Exchange Rate Effect is -$1240.0 (2024), against an average of -$8453.2.
  • The largest YoY upside for Exchange Rate Effect was 3097.82% in 2025 against a maximum downside of 281.05% in 2025.
  • A 3-year view of Exchange Rate Effect shows it stood at $4372.0 in 2023, then plummeted by 172.62% to -$3175.0 in 2024, then tumbled by 80.91% to -$5744.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Exchange Rate Effect are -$5744.0 (Q4 2025), $10738.0 (Q3 2025), and $37173.0 (Q2 2025).